Cetera Advisors LLC recently purchased shares of ARK Genomic Revolution ETF (BATS:ARKG), according to Defense World. The ETF focuses on companies involved in genomics, molecular diagnostics, and bioinformatics. This purchase by Cetera Advisors LLC indicates their interest in the genomic revolution and the potential growth of companies in this sector. The ETF allows investors to diversify their portfolios and capitalize on the advancements in genomics and related fields. Overall, this purchase reflects a positive outlook on the future of genomics and its impact on various industries.